GUARDANT HEALTH INC (1GH.MI) Stock Price & Overview
BIT:1GH • US40131M1099
The current stock price of 1GH.MI is 93.62 EUR. Today 1GH.MI is down by -3.23%.
1GH.MI Key Statistics
- Market Cap
- 12.062B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.76
- Dividend Yield
- N/A
1GH.MI Stock Performance
1GH.MI Stock Chart
1GH.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1GH.MI.
1GH.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1GH.MI. While 1GH.MI seems to be doing ok healthwise, there are quite some concerns on its profitability.
1GH.MI Earnings
On October 29, 2025 1GH.MI reported an EPS of -0.74 and a revenue of 265.20M. The company missed EPS expectations (-2.26% surprise) and beat revenue expectations (9.24% surprise).
1GH.MI Forecast & Estimates
33 analysts have analysed 1GH.MI and the average price target is 104.46 EUR. This implies a price increase of 11.58% is expected in the next year compared to the current price of 93.62.
For the next year, analysts expect an EPS growth of 39.51% and a revenue growth 33.06% for 1GH.MI
1GH.MI Groups
Sector & Classification
1GH.MI Financial Highlights
Over the last trailing twelve months 1GH.MI reported a non-GAAP Earnings per Share(EPS) of -2.76. The EPS increased by 1.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.23% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
1GH.MI Ownership
1GH.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 12.22 | 26.134B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.52 | 23.297B | ||
| EUK | EUKEDOS SPA | N/A | 14.099M | ||
| V3V | FAMICORD AG | N/A |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1GH.MI
Company Profile
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 1,999 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
Company Info
GUARDANT HEALTH INC
3100 Hanover Street
Palo Alto CALIFORNIA US
Employees: 1999
Phone: 18556988887
GUARDANT HEALTH INC / 1GH.MI FAQ
What does 1GH do?
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 1,999 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
What is the stock price of GUARDANT HEALTH INC today?
The current stock price of 1GH.MI is 93.62 EUR. The price decreased by -3.23% in the last trading session.
Does 1GH stock pay dividends?
1GH.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1GH stock?
1GH.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of 1GH stock?
GUARDANT HEALTH INC (1GH.MI) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the number of employees for GUARDANT HEALTH INC?
GUARDANT HEALTH INC (1GH.MI) currently has 1999 employees.
What is GUARDANT HEALTH INC worth?
GUARDANT HEALTH INC (1GH.MI) has a market capitalization of 12.06B EUR. This makes 1GH.MI a Large Cap stock.